ABSTRACT
Background
Stickler syndrome (STL) is a collagenopathy caused by pathogenic variants in collagen-coding genes, mainly COL2A1 or COL11A1 associated with Stickler syndrome type 1 (STL1) or type 2 (STL2), respectively. Affected individuals manifest ocular, auditory, articular, and craniofacial findings in varying degrees. Previous literature and case reports describe high variability in clinical findings for patients with STL. With this case report, we broaden the clinical spectrum of the phenotype.
Materials and methods
Case report on two members of a family (mother and son) including clinical examination and genetic testing using targeted trio whole exome sequencing (trio-WES).
Results
A boy and his mother presented with microphthalmia, congenital cataract, ptosis, and moderate-to-severe sensorineural hearing loss. Trio-WES found a novel heterozygote missense variant, c.4526A>G; p(Gln1509Arg) in COL11A1 in both affected individuals.
Conclusions
We report a previously undescribed phenotype associated with a COL11A1-variant in a mother and son, expanding the spectrum for phenotype-genotype correlation in STL2, presenting with microphthalmia, congenital cataract, and ptosis not normally associated with Stickler syndrome.
Abbreviation
D | = | Diopters |
ID | = | Intellectual Disability |
IOP | = | Intraocular pressure |
MRI | = | Magnetic resonance imaging |
MS | = | Marshall syndrome |
NGS | = | Next-generation sequencing |
Trio-WES | = | Trio exome analysis |
STL2 | = | Stickler syndrome type 2 |
WES | = | Whole exome sequencing |
Acknowledgments
We thank the family for their participation.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Authorship
All listed authors meet the Taylor & Francis authorship criteria as well as the Vancouver criteria.
Guidelines
This case report complies with the CARE guidelines.
Patient consent
Written informed consent was obtained from the patient (I-1) and the patient’s parents (II-2) for publication of this case report to the journal.